Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
Dow
AstraZeneca
Medtronic
Baxter
Johnson and Johnson

Last Updated: November 15, 2019

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: INDINAVIR SULFATE

See Plans and Pricing

« Back to Dashboard

INDINAVIR SULFATE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Merck Sharp Dohme CRIXIVAN indinavir sulfate CAPSULE;ORAL 020685 NDA Merck Sharp & Dohme Corp. 0006-0571-43 360 CAPSULE in 1 BOTTLE (0006-0571-43)
Merck Sharp Dohme CRIXIVAN indinavir sulfate CAPSULE;ORAL 020685 NDA Merck Sharp & Dohme Corp. 0006-0573-62 180 CAPSULE in 1 BOTTLE (0006-0573-62)
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Merck
Dow
AstraZeneca
Harvard Business School